Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
Jun-Qing Jin, Jeong-Sun Han, Jeonghoon Ha, Han-Sang Baek, Dong-Jun Lim
Endocrinol Metab. 2021;36(5):1095-1110.   Published online 2021 Oct 14     DOI: https://doi.org/10.3803/EnM.2021.1155
Citations to this article as recorded by Crossref logo
Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids
Salvatore Benvenga, Fausto Famà, Laura Giovanna Perdichizzi, Alessandro Antonelli, Gabriela Brenta, Francesco Vermiglio, Mariacarla Moleti
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Identifying and categorizing compounds that reduce corneal transforming growth factor beta induced protein levels: a scoping review
Gabriella Guo Sciriha, Janet Sultana, Joseph Borg
Expert Review of Clinical Pharmacology.2022; 15(12): 1423.     CrossRef